SBIR Phase I: An Innovative Photobioreactor for Commercial Production of Astaxanthin from Genetically Improved Haematococcus Pluvialis Strains

该小型企业创新研究（SBIR）第一阶段项目旨在开发一种创新的大型光生物反应器，用于从红球藻菌株中生产天然虾青素。第一阶段的研究计划是建立和评估一个创新的模块化平板光生物反应器的生物体的大规模培养。改进的生产系统，沿着遗传改进的红球藻菌株将使虾青素的生产率提高约50%。这种光生物反应器的发展是唯一的手段，通过它的遗传改良的红球藻菌株的商业潜力可以在商业上实现。该项目的成功将导致中试规模工厂的进一步发展以及反应堆的额外用途。

This Small Business Innovative Research (SBIR) Phase I project aims to develop an innovative large-scale photobioreactor for production of natural astaxanthin from Haematococcus strains. The phase I research plan is to construct and evaluate an innovative modular flat-plate photobioreactor for mass culture of the organism. The improved production system, along with a genetically improved Haematococcus strains will increase the productivity of astaxanthin by an estimated 50%. The development of this photobioreactor is the only means by which the commercial potential of the genetically improved Haematococcus strains can be commercially realized. The success of the project will lead to further development of pilot-scale plants as well as additional uses for the a reactor.